Navigation Links
ZyGEM Corp. Signs Agreement to Incorporate Its Breakthrough DNA Extraction Technology Into Rubicon's Research and Diagnostic Products
Date:5/28/2009

n products is the most recent in a series of ZyGEM collaborations for our versatile technology, and we look forward to a productive and expanding relationship with Rubicon, an emerging leader in pre-analytical amplification of clinical samples."

Rubicon will soon launch its PicoPlex(TM) kits, which integrate ZyGEM's proprietary DNA extraction technology into a novel method to amplify single genomes with unsurpassed accuracy and reproducibility. This product targets the pre-implantation genetic diagnostics and cancer diagnostics markets, which require rapid, reproducible amplification to profile patient genotypes, karyotypes and mutations. PicoPlex enables reference labs to begin qPCR, microarray or sequencing analysis less than three hours after collecting patient cells. PicoPlex is designed to be faster, more accurate and more reproducible than other methods for single cell DNA amplification.

"We believe that the growing customer base for our pre-analytical solutions for DNA and RNA analysis will benefit from access to the unique nucleic acid extraction technology developed by ZyGEM," said James Koziarz, acting president and CEO of Rubicon. "We have greatly improved the clinical performance of whole genome amplification by incorporating ZyGEM technology and other proprietary reagents into our kits, which have been shown to increase the sensitivity, specificity and robustness of most research and diagnostic analytical platforms."

Further terms of the agreement were not disclosed.

Separately, ZyGEM announced that the United States Patent Office has issued an allowance for its patent application covering the unique thermophilic enzymes that are the core component of the company's nucleic acid extraction technology, which is currently marketed in prepGEM(TM), forensicGEM(TM) and livestockGEM(TM) kits, and also through private label agreements with a growing number of partners a
'/>"/>

SOURCE ZyGEM Corp. Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ZyGEM Appoints Leading Biotechnology Expert to Head Clinical Advisory Board
2. ZyGEM and DIAGNOTEC Collaborate on Diagnostics for Detecting a Devastating Virus Attacking Salmon
3. ZyGEM and Advalytix Partner to Produce Innovative DNA Extraction Products
4. Commonwealth Biotechnologies Presents Data at Forensic Sciences Meeting Confirming Benefits of ZyGEMs DNA Extraction Technology
5. ZyGEM Corp. and VWR International Europe BVBA Sign Agreement to Distribute Breakthrough DNA Extraction Technology in Europe
6. ZyGEM Releases Application Note Showing its DNA Extraction Kits Rapidly Produce High Yields of Quality DNA
7. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
8. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
9. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal Year 2007 on September 12, 2007
10. ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results
11. MAKO Surgical Corp. Files Registration Statement for Initial Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 22, 2014 Patients who were treated with a statin ... were significantly more likely to survive than those who ... JAMA Neurology . This study was conducted by ... of cholesterol-lowering statins can improve survival in victims of ... or obstruction of a blood vessel that blocks blood ...
(Date:9/22/2014)... NEW YORK and SANTA CLARA, ... Health Corp. (NASDAQ: WBMD ), the leading ... a new WebMD/Medscape survey that provide novel ... role in aiding diagnosis and care.  Dr. Eric ... genomics and digital medicine, who serves as both Editor-in-Chief ...
(Date:9/22/2014)... components developed by researchers at the USC Viterbi ... build a 3-D microfluidic system quickly and cheaply ... , Microfluidic systems are used in many ... manipulate small volumes of fluids for use in ... detection, clinical diagnostic testing, and synthetic chemistry. Traditionally, ...
(Date:9/22/2014)... tumor cells (CTCs) in a mouse model of pancreatic ... groups of CTCs, including significant differences from the primary ... metastases. In their study reported in the Sept. ... the Massachusetts General Hospital (MGH) Cancer Center identified several ... that may prove to be targets for improved treatment ...
Breaking Biology Technology:Statin use during hospitalization for hemorrhagic stroke associated with improved survival 2WebMD/Medscape Digital Technology Survey Reveals Unique Insights Into How Patients and Physicians Perceive the Role, Potential and Risks Associated with Digital Health Technologies 2WebMD/Medscape Digital Technology Survey Reveals Unique Insights Into How Patients and Physicians Perceive the Role, Potential and Risks Associated with Digital Health Technologies 3WebMD/Medscape Digital Technology Survey Reveals Unique Insights Into How Patients and Physicians Perceive the Role, Potential and Risks Associated with Digital Health Technologies 4Lego-like modular components make building 3-D 'labs-on-a-chip' a snap 2Lego-like modular components make building 3-D 'labs-on-a-chip' a snap 3Lego-like modular components make building 3-D 'labs-on-a-chip' a snap 4Lego-like modular components make building 3-D 'labs-on-a-chip' a snap 5Massachusetts General study reveals gene expression patterns in pancreatic CTCs 2Massachusetts General study reveals gene expression patterns in pancreatic CTCs 3
... Patent 7,507,704 issued on 03/24/09 to NexGen Biomedical, ... an improved method of treating lung, brain, pancreatic, breast ... known as HER1 overexpression (also called EGFR or c-ErbB-1). ... concurrent HER1 blocker / S-Phase cytotoxic protocols achieve only ...
... -- WuXi AppTec (NYSE: WX ), a ... with operations in China and the United States, today,announced ... (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ) , ... joined WuXi AppTec as Vice President of Toxicology and,Head ...
... Release Hospitals Highlights Early Clinical Benefits and Patient ... MASI ), the inventor of Pulse ... announced today that it has initiated the full ... hemoglobin (SpHb(TM)) monitoring technology. As the first noninvasive ...
Cached Biology Technology:Patent for Making Combination Chemotherapy Work Better 2WuXi AppTec Welcomes Three Senior Professionals 2Masimo Initiates Full Market Release of First-Ever Noninvasive Continuous Hemoglobin Monitor 2Masimo Initiates Full Market Release of First-Ever Noninvasive Continuous Hemoglobin Monitor 3Masimo Initiates Full Market Release of First-Ever Noninvasive Continuous Hemoglobin Monitor 4Masimo Initiates Full Market Release of First-Ever Noninvasive Continuous Hemoglobin Monitor 5Masimo Initiates Full Market Release of First-Ever Noninvasive Continuous Hemoglobin Monitor 6
(Date:9/23/2014)... Although the immediate welfare consequences of removing infant chimpanzees ... about the long-term impacts of this type of early ... Park Zoon observed 60 chimpanzees and concluded that those ... and raised by humans as pets or performers are ... , The multi-institutional research project, published today in the ...
(Date:9/22/2014)... the University of Chicago have shown that after a ... a handful of pathogenic microbe species remain behind in ... discovered that some can become deadly when provoked by ... , The findings, published in mBio , the ... may lead to better monitoring and treatment of ICU ...
(Date:9/22/2014)... Many native species have vanished from tropical islands ... scientists have discovered how fossils can be used ... lies in organic materials found in fossil bones, ... according to a new study available online and ... of Herpetology . Pre-human island ecosystems provide vital ...
Breaking Biology News(10 mins):Chimpanzees raised as pets or performers suffer long-term effects on their behavior 2Critically ill ICU patients lose almost all of their gut microbesand the ones left aren't good 2Critically ill ICU patients lose almost all of their gut microbesand the ones left aren't good 3Answer to restoring lost island biodiversity found in fossils 2
... Hopkins neuroscientists has worked out how some newly discovered ... with the brain. The report appears online this week ... are a small number of nerve cells in the ... in the retinarods and conesmelanopsin-containing cells are not used ...
... While examining patterns of DNA modification in lung cancer, ... is a surprising new mechanism. They say that "silencing" of ... impairment in genome-wide changes in cells, contributing to cancer development ... Cancer Research , a journal of the American Association ...
... will be one step closer to better drought-tolerant soybean ... database of all proteins and metabolites in soybeans. Once ... in proteins and metabolites in soybeans grown under drought ... the recently released soybean genome, scientists will have a ...
Cached Biology News:Bright lights, not-so-big pupils 2Bright lights, not-so-big pupils 3In lung cancer, silencing one crucial gene disrupts normal functioning of genome 2In lung cancer, silencing one crucial gene disrupts normal functioning of genome 3Soybean database will help breeders engineer better-performing plants 2
Phosphatidylinositol transfer protein beta isoform (PtdIns transfer protein beta) (PtdInsTP) (PI-TP-beta). [Source:Uniprot/SWISSPROT;Acc:P48739] Antigen: Recombinant Protein Epitope Signature Tag...
Desmosomal Protein Immunogen: Full length, native protein purified from human epidermal keratins. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Mouse monoclonal [SPM217] to Secretory Component Glycoprotein ( Abpromise for all tested applications)....
Mouse monoclonal [3G8] to MDMA ( Abpromise for all tested applications)....
Biology Products: